Currently submitted to: JMIR mHealth and uHealth
Date Submitted: Jul 21, 2026
Open Peer Review Period: Jul 28, 2026 - Sep 22, 2026
(currently open for review)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Continuous Mattress-Derived Passive Sensing as a Low-Burden Monitoring Layer Supporting Comprehensive Geriatric Assessment in Long-Term Care: A Feasibility and Clinical-Utility Study
ABSTRACT
Background:
Comprehensive geriatric assessment (CGA) is performed intermittently, leaving long intervals during which a resident's status may change unobserved. Continuous, low-burden passive sensing could supplement CGA, but the field has tended to overstate predictive value using single-split designs and imbalance-sensitive metrics. The realistic, deployable value of such sensing must be established with rigorous validation.
Objective:
To evaluate (1) the feasibility of long-term mattress-based passive sensing in long-term care and (2) whether the resulting behavioral phenotype is clinically useful as a between-assessment monitoring and triage layer for key CGA domains — explicitly not as a replacement for, or direct predictor of, CGA scores.
Methods:
Retrospective analysis of 192 long-term care residents aged ≥65 years at baseline, continuously monitored with the WhizPad mattress sensor. We quantified data coverage, then built daily-resolution behavioral-phenotype features over 7/14/30-day windows preceding each CGA assessment. For a primary domain (pressure-injury risk, Braden Scale) and a secondary domain (activities of daily living, ADL, Barthel Index) we evaluated discrimination of the higher-need band using unseen-resident (subject-wise) cross-validation (GroupKFold) with resident-cluster bootstrap 95% confidence intervals, calibration (Brier score and reliability), and clinical utility (decision-curve net benefit versus reassess-all and reassess-none strategies). A validation-methodology analysis quantified how naive designs overstate performance.
Results:
Sensing was feasible at scale: median monitoring span 1320 days (~3.6 years), median 1196 resident-days with data, 91% daily coverage, and 226,239 total resident-days. Under unseen-resident validation the sensor phenotype discriminated the higher-need band with an AUROC of 0.654 (95% CI 0.595–0.706) for pressure-injury risk and 0.713 (0.664–0.758) for ADL. Decision-curve analysis showed positive net benefit over both default strategies at decision thresholds of 0.30–0.60 (pressure injury) and 0.20–0.60 (ADL). Feature importance was mechanistically coherent, dominated by in-bed posture/position and movement signals. The methodology analysis showed that an imbalanced three-class macro-F1 endpoint and same-resident temporal validation substantially overstated apparent value: a status-proxy AUROC of ~0.76 under same-resident temporal splitting fell to ~0.62 under unseen-resident validation.
Conclusions:
Continuous mattress sensing is feasible at scale and provides a modest but genuinely useful low-burden monitoring/triage signal for selected CGA domains, adding net clinical benefit at realistic decision thresholds despite modest discrimination. It is best positioned as a surveillance aid between assessments, not a CGA substitute. We provide a validation protocol to curb the overoptimistic claims common in this field and define the design changes required to strengthen the signal.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.